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Abstract
The canonical ATP-dependent protease Lon participates in an assortment of biological processes in bacteria, including the
catalysis of damaged or senescent proteins and short-lived regulatory proteins. Borrelia spirochetes are unusual in that they
code for two putative ATP-dependent Lon homologs, Lon-1 and Lon-2. Borrelia burgdorferi, the etiologic agent of Lyme
disease, is transmitted through the blood feeding of Ixodes ticks. Previous work in our laboratory reported that B. burgdorferi
lon-1 is upregulated transcriptionally by exposure to blood in vitro, while lon-2 is not. Because blood induction of Lon-1 may
be of importance in the regulation of virulence factors critical for spirochete transmission, the clarification of functional roles
for these two proteases in B. burgdorferi was the object of this study. On the chromosome, lon-2 is immediately downstream
of ATP-dependent proteases clpP and clpX, an arrangement identical to that of lon of Escherichia coli. Phylogenetic analysis
revealed that Lon-1 and Lon-2 cluster separately due to differences in the NH2-terminal substrate binding domains that may
reflect differences in substrate specificity. Recombinant Lon-1 manifested properties of an ATP-dependent chaperone-
protease in vitro but did not complement an E. coli Lon mutant, while Lon-2 corrected two characteristic Lon-mutant
phenotypes. We conclude that B. burgdorferi Lons -1 and -2 have distinct functional roles. Lon-2 functions in a manner
consistent with canonical Lon, engaged in cellular homeostasis. Lon-1, by virtue of its blood induction, and as a unique
feature of the Borreliae, may be important in host adaptation from the arthropod to a warm-blooded host.
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Introduction
In nature, Borrelia burgdorferi, the agent of Lyme disease [1,2],
must adapt to disparate hosts, alternating between Ixodes ticks and
various small rodent species. It is thought that this adaptation is
made possible through the remodeling of the spirochete outer
surface in response to environmental cues such as temperature
[3,4,5], blood [6], pH [7,8,9,10], and microbial density [11,12,13].
A recognized example of this is the reciprocal expression of outer
surface lipoprotein (Osp) AB and OspC. OspA and OspB are
dominantly expressed when the spirochete is in culture or in the
midgut of a flat unfed tick, then downregulated upon feeding and
subsequent exposure to blood, increased temperature, and a drop
in pH. OspC is concomitantly upregulated [3,14,15,16]. At this
time the spirochetes experience a period of vigorous growth and
migrate from the tick midgut to the salivary glands via the
hemolymph [17]. This is followed by transmission to the
mammalian host. The coordinated expression of OspAB and
OspC has been proposed as an example of spirochete-vector
interaction, with OspAB and OspC being implicated in spirochete
adhesion to the tick midgut [18,19,20] and salivary gland
respectively. At the time of feeding, abundant, surface exposed
OspA and OspB need to be broken down to remodel the outer
membrane. We have had a long-standing interest in the proteases
of B. burdorferi and their functions. In the absence of known
secreted proteases in the genome of B. burgdorferi [21], we have
documented the reliance of this organism on borrowed proteolytic
activity. The plasminogen activation system is used by the
spirochete to cross cellular and extracellular matrices by inducing
the production of and/or incorporating enzymatically active
plasmin, urokinase plasminogen activator, and metalloproteases
onto its surface [15,22,23,24,25] in both vectors and vertebrate
hosts. While plasmin was important in promoting the migration of
B. burgdorferi through the tick, this mammalian protease did not
have an effect on the remodeling the outer surface of the
spirochete at this crucial time. However, OspC, which is the
upregulated lipoprotein during tick feeding is a plasminogen
receptor [26] providing further indication that this system is
associated with migration of the spirochete in the vector.
In a previous study, our interest in the proteolytic remodeling of
outer surface lipoproteins during the transition of the spirochete
from tick to mammalian host led us to examine the B. burgdorferi
transcriptome after exposure in vitro to increased temperature in
the presence and absence of blood [6]. The changes that we
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OspC, other lipoproteins, and many genes of known or unknown
function. One intriguing observation was the significant upregula-
tion of a putative ATP-dependent protease La (Lon-1, BB0253)
[21], a homolog of the Escherichia coli lon gene [27] and identical to
the lon gene described for B. burgdorferi by Cloud et al. [28]. The B.
burgdorferi genome also codes for a second putative ATP-dependent
lon homolog, BB0613 (lon-2) [21], which was not differentially
expressed in the array [6].
The canonical E. coli Lon (Lon-Ec), a conserved and much
studied protease important for intracellular degradation of short-
lived and abnormal proteins [27], has also been identified as a
DNA-binding protein [29], and as a part of the heat shock regulon
[30,31]. Besides bacteria, Lon homologs have also been found in
other organisms including archaea [32], yeast [33,34,35], and
animals [36,37]. It is an 87-kDa oligomeric serine protease with a
structure consisting of three functional domains: the heteroge-
neous NH2-terminal (LAN) domain, the ATPase domain, and the
C-terminal proteolytic domain. Structural studies have demon-
strated that Lon is a ring-shaped complex composed of multiple
identical 87-kDa subunits, with Lon-Ec functioning as a hexamer
[38]. Lon plays an important role in homeostasis by targeting
abnormal proteins and unstable regulatory proteins such as the
SulA division regulator [39] and RcsA, the positive regulator of
capsular polysaccharide [40,41], and degrading tmRNA-tagged
proteins during trans translation [42]. In addition, Lon has been
shown to be a virulence factor for infection in mice [43,44]. Our
interest in B. burgdorferi Lon-1 stemmed from the idea that as a
protease, it could take part in the remodeling of the spirochete
outer surface during the period following a blood meal in the tick.
With this in mind, we sought to identify functional roles for Lon-1
and Lon-2 through phylogenetic analysis, and biochemical and
genetic means. Our results support the idea that Lon-2 fulfills the
role of canonical Lon and is involved in cellular quality control
and homeostasis, while Lon-1 plays a role in host adaptation
during the transition from tick to mammal.
Results/Discussion
Spirochetal Lon-1 and Lon-2 are only distantly related to
canonical Lon
B. burgdorferi codes for two putative ATP-dependent Lon
homologs designated Lon-1 and Lon-2 [21]. In a previous study,
Lon-1 was upregulated in response to blood, while Lon-2 was not
[6], though each is expressed by B. burgdorferi during culture in
BSK-H medium (Figure 1A). The presence of more than one lon
gene homolog is rare in the eubacteriae, but appears to be a
unique characteristic of the genus Borrelia, as the genomes for B.
afzelii [45], B. garinii [46], B. recurrentis [47], B. duttoni [47], and B.
hermsii [48] also code for two Lon homologs. Our interest in Lon-1
stemmed from its hypothetical function as a protease, and we
hypothesized that it could be involved in the remodeling of
spirochete outer surface lipoproteins during the transition from the
tick to the mammal, thus warranting its investigation as a potential
virulence factor. By extension, our hypothesis would imply that
Lon-2 would likely function in a manner similar to that of Lon-Ec.
The canonical Lon-Ec resides on the chromosome, adjacent to and
downstream from two other ATP-dependent proteases, clpP and
clpX, the proteolytic subunits comprising the ATP-dependent
clpXP complex thought to share its role in cellular housekeeping.
Examination of the chromosomal location of B. burgdorferi lon-2
reveals that it is arranged identically, immediately downstream of
clpX and clpP, while Lon-1 is on a distant part of the chromosome
(Figure 1). The lon-2 arrangement shown for B. burgdorferi in
Figure 1 is maintained in other Borrelia, while Treponema and
Leptospira code for single lon genes that are not arranged in the
same fashion as canonical lon (data not shown).
Because the similarity of the chromosomal location of Lon-2 to
canonical E. coli lon suggested that they could serve a similar
function, we tested the premise that Lon-1 of B. burgdorferi may
have other functions that could be unique to spirochetes, as
transcription of this gene was upregulated on blood induction. Our
assessment of the premise began with comparison of amino acid
sequences (defined by Pfam, PF00004, PF02190, and PF05362) of
Borrelia Lons with the Lon sequences of other spirochetes and more
distantly related bacteria through the construction of phylogenetic
trees (Figure 2). The trees we created included Lon amino acid
sequences from spirochetes coding for two Lons (Lyme disease and
relapsing fever Borreliae) and single Lons (Treponema, Leptospira, E.
coli, and B. subtilis). In Figure 2A, a tree based on the entire amino
acid sequences of Lon proteins is shown. One evident feature from
the tree is that while all of the Lons are related to some extent, they
began to diverge in the distant past. The Borrelia Lon-1s cluster
together, indicating that they are closely related. Within the Lon-1
group, the relapsing fever Borreliae, consisting of B. recurrentis, B.
duttoni, and B. hermsii form a subcluster, while the Lyme disease
group, B. burgdorferi, B. afzelii, and B. garinii form another
subcluster. Although distinct, Borrelia Lon-1 is also related to Lons
of Treponema and Leptospira, suggesting a common ancestor. Lon-2
sequences from Lyme disease and relapsing fever Borreliae cluster
separately from all the other bacteria, indicating a close
relationship exclusive to the genus Borrelia, and form subclusters
identical to those of Lon-1. We also performed the phylogenetic
analyses using lon nucleotide sequences, with virtually identical
results (data not shown).
The carboxy-terminal proteolytic domain and the ATPase
domain of Lon are conserved across different bacterial species,
whereas the NH2-terminal domain, which is responsible for
substrate binding, is heterogeneous, and thus, the most useful for
phylogenetic analysis. To determine a possible functional differ-
ence between Lon-1 and Lon-2, we tested the phylogenetic
Author Summary
Lyme disease, caused by the spirochete Borrelia burgdorferi,
is the most prevalent arthropod-borne disease in North
America. In nature, the bacterium oscillates between its tick
vector host (Ixodes spp.) and small rodents (Peromyscus
spp.). B. burgdorferi is able to persist in these two very
different host environments by modulating the expression
of surface lipoproteins proteins, or other proteins, in
response to host factors or environmental cues such as
temperature and pH. Our interest in this process led to the
identificationof a homolog of the E. coli ATP-dependent lon
protease (lon-1)i nB. burgdorferi that was upregulated in
response to blood. The prototypical Lon of E. coli is a
conserved protease important for the destruction of
abnormal and short-lived proteins. B. burgdorferi is unusual
in that it also codes for a second lon homolog, lon-2, that
was not upregulated in response to blood. In this study, we
sought to clarify the roles for Lon-1 and Lon-2 in B.
burgdorferi. We present evidence that Lon-1 is an ATP- and
Mg
2+-dependent protease but does not function in a
manner consistent with a prototypical Lon. Lon-2, however,
functionally complemented Lon in E. coli. Thus, Lon-1 and
Lon-2 appear to have distinct roles in B. burgdorferi; Lon-1
by virtue of its blood induction may be important in host
adaptation, while Lon-2 is the functional homolog of E. coli
Lon.
Lon-1 and Lon-2 in Borrelia
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in Figure 2A (Figure 2B). Overall, the clustering pattern for the
NH2-terminal domain sequences closely resembles that of the
whole molecule, implying that the clustering is driven by
differences in the NH2-terminal domain alone. Perhaps the most
significant outcome of the phylogenetic analysis is that the NH2-
terminal domains of Lon-1 and Lon-2 are shown to be especially
dissimilar, which may correlate with substrate specificity. Thus,
Lon-1 and Lon-2 may each recognize different substrates. Another
significant outcome of the phylogenetic analysis is that neither
Lon-1 nor Lon-2 are closely related to the canonical Lons of E. coli
and B. subtilis, preventing us from making sequence-driven
inferences about the function of either Borrelia Lon.
Recombinant Lon-1 is enzymatically active
To further examine B. burgdorferi Lon function, we characterized
the Lon-1 gene product to study its structure and test it for
biological activity. For this purpose, we generated wild-type rLon-
1 (strains and PCR primers are given in Tables 1 and 2).
Proteolytic domains of Lons typically contain a lysine-serine dyad
critical for catalysis with the lysine appearing 43 residues
downstream of the catalytic serine [38]. Inspection of the deduced
Lon-1 amino acid sequence shows that it contains a serine residue
a position 714 (Swiss-Prot predicted active site S714) and a lysine
at position 757 (Swiss-Prot predicted active site K757), therefore,
we also generated a recombinant with the putative catalytic
serine714 mutated to alanine (S714A) to abolish proteolytic
activity and confirm its identity as part of the catalytic dyad.
Recombinant wild-type (rLon-1) and mutant Lon-1 (rLon-1
S714A)
was analyzed by SDS-PAGE and western blot (Figure 3) to assess
their purity and confirm their size. Figure 3 panels A and B show
that rLon-1 and rLon-1
S714A were purified to homogeneity and
their SDS-PAGE profiles are consistent with their predicted size
(native Lon-1 has a predicted MW of 90,701 and a predicted MW
of 92,864 with the attached His-tag).
To examine the catalytic activities of wild-type rLon-1 and
rLon-1
S714A we conducted ATPase and caseinolytic assays
(Figure 4). Analysis of ATPase activity by a colorimetric dye-
binding assay showed that both the rLon-1 and the rLon-1
S714A
exhibited similar levels of activity (Figure 4A). The ATPase activity
of rLon-1
S714A confirmed that the ATPase and the proteolytic
domains function independently and that introduction of a
mutation into the proteolytic domain does not affect the ability
of Lon-1 to hydrolyze ATP. To test for rLon-1 and rLon-1
S714A
ATP-dependent proteolytic activity we measured the degradation
of a-casein-fluorescein isothiocyanate (FITC-casein), in the
presence of 10 mM ATP and 4 mM ATP [33,37,49]. In contrast
to the ATPase assay, the rLon-1
S714A did not show activity levels
above that of the buffer control while the wild-type rLon-1
degraded FITC-casein in a time-dependent manner (Figure 4B).
This confirms that through targeted mutagenesis of serine714, the
catalytic serine residue was identified correctly. Omission of ATP
from the assay verified that it is required for the degradation of
FITC-casein by rLon-1, as would be expected for an ATP-
dependent protease (Figure 4C, left panel).
T h ep r e s e n c eo fM g
2+ is critical for assembly of both E. coli and
Mycobacterium smegmatis Lon subunits into proteolytic multimeric
structures [50,51]. To investigate whether the caseinolytic
activity of Lon-1 was Mg
2+-dependent we carried out the
caseinolytic assay with wild-type rLon-1 in the presence and
absence of Mg
2+ (for the absence of Mg condition, MgCl2 was
omitted from the reaction buffer). In the presence of Mg
2+ the
catalytic activity was retained, however, the absence of Mg
2+
reducedthe activitytobackgroundlevels (Figure4C, right panel).
Figure 1. Native Lon expression in B. burgdorferi and comparison of lon loci and flanking genes from B. burgdorferi and E. coli. (A)
Native Lon-1 and Lon-2 expression in B. burgdorferi wild-type BB050.14 spirochetes. Lon-1 and Lon-2 were detected in whole cell lysates by use of
rabbit and mouse antiserum, respectively. (B) B. burgdorferi lon-1 region. (C) B. burgdorferi lon-2 region. (D) E. coli lon region. Gene symbols and gene
loci (The Institute for Genomic Research-TIGR) are given above and below each gene, respectively. CH, conserved hypothetical; leuS, leucyl-tRNA
synthase; M23 pdp, M23 peptidase domain protein; tig, trigger factor; clpP, ATP-dependent proteolytic subunit of ClpA-ClpP serine protease; clpX,
ATP-dependent specificity component of ClpP serine protease; rpsD, ribosomal protein S4; hupB, DNA-binding protein HU-beta; ybaU, putative
protease maturation protein. Gene coordinates are indicated with arrows. One-kb size marker is shown at lower left.
doi:10.1371/journal.ppat.1000676.g001
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PLoS Pathogens | www.plospathogens.org 3 November 2009 | Volume 5 | Issue 11 | e1000676Figure 2. Phylogenetic trees based on Lon amino acid sequences of spirochetes. (A) Phylogenetic tree of spirochetes derived from the
amino acid sequences of Lons from reference strains of B. burgdorferi sensu lato and relapsing fever Borrelia, Leptospira and Treponema species with E.
coli and B. subtilis as an external group. (B) Phylogenetic tree of spirochetes derived from the amino acid sequences of the amino-terminal NH2-
terminal domains from reference strains of B. burgdorferi sensu lato and relapsing fever Borrelia, Leptospira and Treponema species, with E. coli and B.
subtilis as outgroups. The neighbour joining trees were constructed with MEGA3 software. Bootstrap confidence levels above 50% are indicated to
left of each relevant cluster. Asterisks: * Lon-1; ** Lon-2. All of the sequences were obtained from Swiss-Prot Protein knowledgebase. Accession
numbers are listed next to each species. Distance marker is shown at lower left for each panel.
doi:10.1371/journal.ppat.1000676.g002
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multimeric structures is essential for proteolytic activity. We also
examined the caseinolytic activity of wild-type rLon-1 over a
gradient of pH conditions. The pH optimum for wild-type rLon-
1 ranged from 9.0 to 9.5, which is similar to that of Lon-Ec [52]
( F i g u r e4 D ) .E x h a u s t i v ea t t e m p t s to overexpress rLon-2 proved
unsuccessful, as the detergent-soluble product was proteolytically
inactive, precluding further use.
Lon-1 does not degrade Borrelia-SsrA tagged reporter
protein in vitro
A variety of in vivo Lon substrates have been identified to date,
including SulA, RcsA, and UmuD [40,53,54,55]. In addition,
rLon-Ec was reported to degrade SsrA-tagged proteins, a
characteristic that could be directly examined in vitro [42]. SsrA
(also known as tmRNA) is a unique RNA molecule that is highly
conserved in Eubacteria and plays a major role in dealing with
stalled ribosomes caused by aberrant mRNAs. In this process,
SsrA co-translationally places a peptide tag on the carboxyl
termini of the incomplete polypeptides. These marked polypep-
tides are recognized by cellular proteases, including Lon, and
readily degraded [56]. The ssrA sequence of B. burgdorferi has been
identified and the presence of SsrA RNA product has been
confirmed [57]. To test whether Lon-1 can degrade proteins
marked with a Borrelia-SsrA tag, we constructed and purified a
reporter protein, l-CI-N-SsrA
Bb, which carries a Borrelia-SsrA
Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid name Genotype or description Reference or source
B. burgdorferi B31MI MedImmune strain, wild-type Reference [21]
B31A3 cp9 , – wild-type Reference [74]
E. coli BL21 Star
TM(DE3)pLysS Expression host, F– ompT hsdSB (rB–, mB–)
gal dcm rne131 (DE3) pLysS (CamR)
Invitrogen, Carlsbad, CA
Rosetta
TM 2(DE3)pLysS Expression host, F- ompT hsdSB (rB- mB-)
gal dcm (DE3) pLysS RARE2 (CamR)
Novagen, Gibbstown, NJ
HDB97 SG22622 mal+, wild-type lon Reference [68]
HDB98 HDB97 (lon
510) Reference [68]
HDB98pBAD24 HDB98 containing pBAD24 This study
HDB98pBADlon-1 HDB98 containing pBAD24lon-1 This study
HDB98pBADlon-2 HDB98 containing pBAD24lon-2 This study
Plasmids pET30a(+) Expression vector Novagen
pCK003.9 pET30a(+) expressing wt rLon-1 This study
pCK004.3 pET30a(+) expressing rLon-1
S714A This study
pCK006.2 pET30a(+) expressing wt rLon-2 This study
pBAD24 Expression vector containing PBAD Reference [75]
pBADlon-1 pBAD24 with lon-1 cloned in This study
pBADlon-2 pBAD24 with lon-2 cloned in This study
doi:10.1371/journal.ppat.1000676.t001
Table 2. Oligonucleotide primers used in this study.
Primer Pair RS
a Primer sequence (59R39) Application
P1F
P2R
NdeI
XhoI
TTACATATGGATGAATCTAAAAAAGCTAGG
TTACTCGAGAAACAATAATTTAATGACCTCG
Amplification of lon-1 for cloning into pET30a
P21F
P22R
NdeI
XhoI
CTCCCATATGAAATCAATCTTAAATATGA
AACCCTCGAGAATAATATTCAAATAATCAAAAACTTC
Amplification of lon-2 for cloning into pET30a
P3F
P4R
—
—
CCCAAAAGATGGGCCTGCTGCAGGAATTAC
AGCTATTGTAATTCCTGCAGCAGGCCCATC
Amplification of lon-1 for site-directed mutagenesis
P23F
P24R
—
—
CCAAAAGATGGGCCTGCTGCAGGTATTACCATTGCAAC
GTTGCAATGGTAATACCTGCAGCAGGCCCATCTTTTGG
Amplification of lon-2 for site-directed mutagenesis
P50F
P51R
NcoI
NcoI
CGCGAGCCATGGATGAATCTAAAAAAGCTAGG
CGCGAGCCATGGTTAAAACAATAATTTAATGACC
Amplification of lon-1 for cloning into pBAD24
P52F
P53R
NheI
KpnI
CGCGAGGCTAGCAGGAGGAATTCACCATGATAAAAAATAGAAAAGAAG
CGCGAGGGTACCTTAAATAATATTCAAATAATC
Amplification of lon-2 for cloning into pBAD24
All PCR primers shown here were designed for this study.
aRestriction sites are underlined.
doi:10.1371/journal.ppat.1000676.t002
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observed two distinct protein bands of similar sizes, most likely
artifacts of the purification procedure (Figure 5B, low MW
proteins). Analysis of each protein by MALDI-TOF mass
spectroscopy showed that the higher molecular weight protein
is l-CI-N-SsrA
Bb containing a full-length SsrA tag, and the lower
m o l e c u l a rw e i g h ti st h es a m ep r o t e i nw i t hat r u n c a t e dS s r At a g
(Figure 5A). Next, we performed in vitro degradation assays using
purified rLon-1 or rLon-Ec and the reporter protein to directly
evaluate Lon activity. Assays showed that rLon-1 degraded
neither tagged l-CI-N reporter nor truncated tagged l-CI-N
reporter proteins (Figure 5B,C). Interestingly, rLon-Ec could
effectively degrade tagged l-CI-N reporter despite a significant
amino acid sequence difference between Borrelia and E. coli SsrA
tags. Truncated SsrA tagged reporter protein was not degraded
by rLon-Ec, suggesting that it specifically recognized the SsrA
tag,notthel-CI-N proteinitself. Furthermore, rLon-Ec required
ATP for the degradation of the l-CI-N-SsrA
Bb reporter protein
(Figure 5C).
To further analyze the protease activity of Lon in vitro, we used
insulin as a substrate in an in vitro assay similar to that of the tagged
l-CI-N reporter. Assays showed that both Lon-1 and Lon-Ec
could effectively degrade insulin (Figure 5D). These results suggest
that unlike Lon-Ec, Lon-1 of B. burgdorferi is an active protease that
does not recognize Borrelia-SsrA tagged proteins in vitro.
Mutant Lon-1 inhibits the aggregation of insulin b-chain
In addition to its function as an ATP-dependent protease, Lon
exhibits a chaperone-like role in mammalian mitochondria, yeast,
and bacteria [58,59,60,61,62]. Cloud et al. [28] reported that
complementation of an E. coli lpxA temperature-sensitive mutant
with sequence corresponding to the N-terminus and ATP-binding
site of B. burgdorferi lon-1 allowed the mutant to grow at the non-
permissive temperature. One reason for the suppression of the
temperature-sensitive phenotype could be a novel chaperone-like
activity conferred to lon-1 through the absence of the proteolytic
domain from the construct, thus allowing stabilization of the
mutant lpxA gene. To further characterize Lon-1 we investigated
its capacity to act as a chaperone by use of an in vitro assay
employing bovine insulin. Insulin is a 6-kDa polypeptide consisting
of two chains, A and B, connected by two disulfide bridges.
Reduction of the molecule results in aggregation of the B-chain,
while the A-chain remains soluble [63]. The chaperone assay is
based upon the prevention of B-chain aggregation through
interaction with an added chaperone. Assay results are measured
via light scattering caused by insulin aggregates [59,61].
Therefore, to determine if rLon-1 possessed chaperone-like
activity, we tested the ability of rLon1 and rLon-1
S714A to inhibit
the aggregation of insulin B-chain under reducing conditions.
Kinetic spectrophotometric analysis revealed that in the absence of
added Lon protein (buffer only), an irreversible formation of B-
chain aggregates was the result. Addition of rLon-1
S714A without
ATP did not significantly affect aggregate formation (Figure 6A,
top panel). However, addition of rLon-1
S714A in the presence of
increasing amounts of ATP resulted in a dose-dependent
inhibition of aggregate formation (Figure 6A, lower panels).
Wild-type rLon-1 enzymatically degraded the insulin and thus was
not suitable for use in the assay (Figure 6B).
The preservation of chaperone-like activity despite mutagenesis
of the proteolytic site in Lon-1 is consistent with that found in yeast
and mammalian Lon [58,60]. The critical requirement for ATP in
our Lon-1 chaperone assay results is in agreement with that
reported for chaperones in general [64] and for yeast Lon [58,60],
but differs with one study in which the chaperone-like activity of a
bacterial Lon was investigated. In that report, Lon from
Brevibacillus thermoruber prevented insulin aggregation in an ATP-
independent manner [59].
Protein stabilization and catalysis would seem to be opposing
actions; nevertheless, ATP-dependent chaperone-proteases of the
Clp and Lon families are well documented [62]. In the case of
Lon-1, the demonstration of a chaperone-like activity in vitro, while
interesting, does not definitively establish a role as a chaperone in
vivo. On the other hand, differential recognition of potential
substrates l-CI-N-SsrA
Bb and insulin or casein by rLon-1
demonstrates an ability by the enzyme to discriminate, implying
that it could act as a chaperone for one protein and degrade
another.
Lon-2 complements an E. coli lon mutant
The implied redundancy of retaining two Lon genes necessarily
raises the question of whether they are in actuality functionally
equivalent, complementary, distinct, or overlapping, which may
be reflected by similarities or differences in composition or
expression pattern. B. burgdorferi Lons-1 and -2 are comparable
in size (,90 kDa) and domain structure. However, Lon-2 may be
more chemically similar to the archetypal Lon-Ec, as suggested by
the similarity of their isoelectric points (Lon-2: pI=6.04/Lon-Ec:
pI=6.32), and the similarity in its chromosomal arrangement to
Lon-Ec. Lon-1, on the other hand, is an exceedingly basic protein
(pI=9.85). In our previous report, lon-1 was transcriptionally
upregulated in vitro when exposed to blood and temperature shift
in comparison to temperature shift alone. Lon-1 upregulation in
response to temperature shift alone was not determined in this
study [6]. However, in other studies, lon-1 was not activated by
temperature [65,66], pH shift [66], or by cultivation in dialysis
membrane chambers in rats [66,67]. In line with our own findings,
none of the above microarray studies reported the differential
expression of lon-2 as a result of any condition [65,66,67].
Figure 3. SDS-PAGE and western blot analysis of purified
recombinant wild-type and mutant (S714A) B. burgdorferi Lon-1
protein. (A) Coomassie blue-stained 12.5% gel of recombinant Lon-1
wild-type (rLon-1) and S714A mutant (rLon-1
S714A). (B) Corresponding
western blot using rabbit polyclonal antiserum.
doi:10.1371/journal.ppat.1000676.g003
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testing experimentally whether either gene is functionally
equivalent to lon-Ec. Use of a complementation strategy allowed
us to investigate and compare the role(s) of lon-1 and lon-2 in an in
vivo context and circumvent the inability to produce rLon-2. Lon-
Ec specifically degrades RcsA, a positive activator for transcrip-
tion of capsular polysaccharide (cps) genes [40,41]. Lon-deficiency
in E. coli causes an accumulation of RcsA and a concommitant
excessof CPS, resulting ina mucoid phenotype.Lon-1 or lon-2 was
inserted into the multiple cloning site of plasmid pBAD24, to
produce plasmids pBADlon-1 and pBADlon-2. Each plasmid was
transformed into lon-deficient strain HDB98 (lon510), which
contains a cpsB::lacZ fusion reporter [68]. Measurement of b-
galactosidase activity allowed us to assess the ability of Lon-1 or
Lon-2 to correct the defect in cpsB regulation by RscA. As shown
in Figure 7A, after culture at 30uC in the presence of 0.1%
arabinose, HDB98 containing pBADlon-1 (HDB98pBADlon-1)
exhibited b-galactosidase activity at levels similar to parental
HDB98 and HDB98 containing vector alone (HDB98pBAD24).
In HDB98pBADlon-2,h o w e v e r ,b-galactosidase activity levels
were significantly reduced in comparison to HDB98,
HDB98pBAD24, and HDB98pBADlon-1 (P,0.001). The reduc-
tion in b-galactosidase levels did not occur in the absence of
arabinose (Figure 7B). Expression of soluble Lon-1 and Lon-2 by
E. coli containing plasmids pBADlon-1 and pBADlon-2 was
verified by western blot (Figure 7C, D, E).
Another substrate for Lon is cell division inhibitor, SulA,
which functions along with FtsZ protein to prevent disadvanta-
geous cell division [39,69]. Accumulation of SulA due to a Lon
deficiency in E. coli causes impaired cell division resulting in a
filamentous morphology, a phenotype exhibited in culture by
lon
510 mutant HDB98 (data not shown). In the presence of 0.2%
arabinose, HDB98pBADlon-1 produced long filamentous forms
similar to the bacteria grown without arabinose and to HDB98,
while in HDB98pBADlon-2, arabinose induction of Lon-2
expression resulted in greatly reduced filament formation
(Figure 8A). Expression of Lon-1 and Lon-2 was verified by
western blot (Figure 8B). The ability of Lon-2 and not Lon-1 to
complement HDB98 for filamentation and dysregulation of cps
implies a differential capacity for these proteases to degrade
RscA and SulA and supports a Lon-Ec-like role for Lon-2 in
Borreliae.
Figure 4. Enzymatic activities of purified recombinant wild-type and mutant Lon-1. (A) Colorimetric determination of hydrolysis of ATP by
wild-type (rLon-1) and mutant (rLon-1
S714A) Lon-1, with or without ATP substrate. (B) Time course of proteolysis of the substrate FITC-casein by rLon-1
and rLon-1
S714A. (C) ATP (left panel) and Mg
2+ (right panel) requirements for proteolysis of FITC-casein by rLon-1. (D) Dependence on pH for
proteolysis of FITC-casein by rLon-1. Experiments shown here are representative of two or more experiments in which similar results were obtained.
Error bars represent the standard deviation of duplicate samples.
doi:10.1371/journal.ppat.1000676.g004
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PLoS Pathogens | www.plospathogens.org 7 November 2009 | Volume 5 | Issue 11 | e1000676We have shown that B. burgdorferi Lons-1 and -2 have
c h a r a c t e r i s t i c si nc o m m o nw i t hc a n o n i c a lL o na n dw i t he a c h
other. Lon-1 protein displayed features of an ATP and Mg
2+-
dependent chaperone-protease, but lon-1 did not complement
an E. coli lon mutant, while lon-2 corrected two distinct lon
mutant phenotypes. Primary structural analysis showed that
their respective ATPase and proteolytic domains are similar
and characteristically Lon-like, but their substrate-binding
domains are very different, suggesting that they may recognize
divergent substrates. Taken together, this suggests that despite
the structural similarities of Lon-1 and Lon-2, they appear to
have distinct functional roles. The presence of Lon-1 as a
unique feature of Borrelia would indicate that it has functions
relevant to this genus as arthropod-transmitted pathogens.
Specifically to B. burgdorferi, Lon-1 may function in host
adaptation where it could be important as a protease during
periods of rapid spirochete proliferation during a bloodmeal
with its associated increases in protein biogenesis. It is also
p o s s i b l et h a td u r i n gt h i sp e r i o d ,L o n - 1c o u l da c ta sac h a p e r o n e
for molecules that are not enzymatic substrates. Lon-2, on the
other hand, functions as the canonical Lon, engaged in cellular
homeostasis.
Materials and Methods
Ethics statement
A l la n i m a lp r o c e d u r e sw e r ep e r f o r m e di nc o m p l i a n c ew i t h
the guidelines and with the approval of the Institutional
Animal Care and Use Committee (IACUC) of Stony Brook
University.
Figure 5. Lon-1 does not degrade l-CI-N reporter protein carrying a Borrelia-SsrA tag. (A) SsrA-encoded proteolysis tags are shown.
Truncated Borrelia SsrA tag refers to the reporter protein carrying a partial SsrA tag (determined by mass spectroscopy). (B) In vitro proteolysis assay
was performed as described and protein samples taken at indicated time points were resolved on 15% polyacrylamide Tris-tricine gel followed by
Coomassie blue staining. Protein bands labeled as tagged and trunc. tagged refer to the l-CI-N reporter protein carrying a full-length or truncated
Borrelia SsrA tag, respectively. Creatine kinase, present in the reaction mixture, was used as a loading control. (C) Protein gels were quantitatively
analyzed using the Odyssey infrared imaging system (LI-COR) and remaining reporter proteins were calculated and presented as a percentage
(average of three independent experiments). Error bars represent standard deviations. (D) Proteolysis assay of insulin was performed in a manner
similar to l-CI-N reporter in vitro assays.
doi:10.1371/journal.ppat.1000676.g005
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For rabbit antiserum to Lon-1, New Zealand white rabbits
were inoculated subcutaneously with 100 mg (400 ml) of
recombinant Lon-1 in Freund’s Complete Adjuvant. The
rabbits were boosted three times over a period of a month
(100 mg in 400 ml) in incomplete Freund’s Incomplete Adjuvant
followed by test a bleed and serological testing by ELISA and
western blot to confirm reactivity to recombinant and native B.
burgdorferi Lon-1. A final boost in PBS was given and the serum
was collected four days later. For mouse antiserum to Lon-2,
BALB/c mice were inoculated subcutaneously with 100 mg
(200 ml) of recombinant Lon-2 in Complete Freund’s Adjuvant.
The mice were boosted subcutaneously (100 mg in 200 ml) two
times with Freund’s Incomplete Adjuvant followed by test a
bleed and serological testing by ELISA and western blot to
confirm reactivity to recombinant and native B. burgdorferi Lon-
2. A final boost in PBS was given and the serum was collected
three days later.
Generation of recombinant proteins
Purified Lon-Ec was a gift of Dr A. Wali Karzai Department of
Biochemistry and Cell Biology, Center for Infectious Diseases,
Stony Brook University, Stony Brook, NY [42]. To generate
recombinant Lon-1, the open reading frame of lon-1 (BB0253) was
PCR amplified from B31MI [21] and ligated into the space
between the NdeI and XhoI restriction sites of predigested vector
pET30a(+) (Novagen, Gibbstown, NJ) using primers P1F and P2R
(Table 2) to produce a construct that incorporated a 6-histidine tag
at the C-terminal end. The resulting plasmid, pCK003.9 (Table 1),
was introduced into BL21 Star
TM(DE3)pLysS (Invitrogen). E. coli
were grown at 37uC in Tryptose Phosphate Glucose medium until
an OD600 of ,0.8 was reached, then induced at 37uC for 3–
4 hours with 1.0 mM IPTG. Cell pellets were resuspended and
sonicated for 30 seconds on ice in HisBind buffer (20 mM Tris
HCl, pH 8.0, 0.5M NaCl, 20 mM imidazole) (Novagen) contain-
ing 0.2% NP40 (Pierce, Rockford, IL). Benzoase nuclease, 0.01%,
(EMD Chemicals, Inc., Gibbstown, NJ) was added and the lysate
was sonicated for an additional two minutes on ice. Clarified lysate
was diluted in buffer A (20 mM Tris HCl, pH 8.0, 0.5M NaCl,
20 mM imidazole, 0.02% NP40) and applied to a column of
HisTrap HP resin (GE Healthcare, Piscataway, NJ). Elution was
carried out in three steps: 15%, 50%, and 100% of buffer B
(20 mM Tris HCl pH 8.0, 0.5M NaCl, 1M imidazole, 0.02%
NP40). The final buffer conditions were 20 mM Tris HCl pH8.0,
0.5M NaCl, 0.02% NP40, 0.5M imidazole, 10% glycerol.
Exhaustive attempts to produce functional recombinant Lon-2
were unsuccessful. All constructs were confirmed by DNA
sequencing. Recombinant protein expression and purification
was done at the NBC Protein Expression Core, Wadsworth
Center, Albany, NY.
Site-directed mutagenesis of the Lon proteolytic domain
The QuicKChange II Site-Directed Mutagenesis Kit (Strata-
gene) and primers P3F and P4R (Table 2) were used to introduce a
point mutation in the proteolytic domain of the lon-1 open reading
frame, converting the catalytically active serine residue to alanine
(S714A). The resulting construct in pET30a(+), pCK004.3
(Table 1) was confirmed by sequencing and used to transform
expression host BL21 Star
TM(DE3)pLysS. Soluble mutant rLon-1
(rLon-1
S714A) was expressed and purified as described above for
wild-type rLon-1.
In vitro proteolysis of Borrelia-SsrA tagged reporter
protein
The purification of l-CI-N reporter protein was performed as
described by Choy et al [42] with some modifications. Briefly,
plasmid pPW500 [70], which encodes the l-cI-N-trpAt gene with
no stop codon, was first modified by site directed mutagenesis. In
this process, the trpAt terminator sequence of the reporter gene
was replaced by the B. burgdorferi ssrA-tag sequence that was
obtained from the tmRNA website (http://www.indiana.edu/
,tmrna/). Thus, the final plasmid construct carried the l-cI-N
gene with the B. burgdorferi ssrA-tag sequence (l-cI-N-ssrA
Bb)a n d
was transformed into an E. coli clpP clpX lon triple mutant.
Bacterial cells were cultured in LB broth at 37uC and reporter
expression was induced for 3 h with 1 mM IPTG when cultures
reached mid-log phase. Finally, the l-CI-N-SsrA
Bb reporter
Figure 6. Chaperone-like activity of rLon-1
S714A, as determined
by prevention of the aggregation of reduced insulin B-chain.
(A) Effect of rLon-1
S714A on aggregation of reduced insulin B-chain in
the absence of ATP (upper panel), in the presence of 4 mM ATP (middle
panel), and in the presence of 10 mM ATP (lower panel). (B) Effect of
wild-type rLon-1 and rLon-1
S714A on reduced insulin as analyzed by Tris-
tricine SDS-PAGE, followed by Coomassie blue staining. For the
digestion, approximately 25 mg of rLon-1 and rLon-1
S714A were
incubated at 37uC for two hours with 150 mg of insulin, in the presence
of 4 mM ATP. Each gel lane received 10 ml of the digestion mixture.
Asterisk shows position of either rLon-1 or rLon-1
S714A. Experiments
shown are representative of two experiments in which similar results
were obtained.
doi:10.1371/journal.ppat.1000676.g006
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an internal His6 epitope as described [42]. The quality of the
purified product was determined by SDS-PAGE followed by
Coomassie blue staining, and the size of each protein band was
verified by MALDI-TOF mass spectroscopy. In vitro proteolysis
assays were carried out with a final concentration of 1.5 mMo f
either rLon-1 or rLon-Ec, 10 mM l-CI-N-SsrA
Bb or 0.3 mg/ml
insulin as substrates, an ATP regeneration system (50 mM
creatine phosphate, 80 mg/ml creatine kinase [56], 4 mM ATP),
and a minimal activity buffer (50 mM Tris-HCl, pH 8.0, 10 mM
MgCl2, 1 mM dithiothreitol). An additional 20 mM of dithio-
threitol was included in assays with insulin. The reaction
mixtures were incubated at 30uC and a fraction of each sample
was collected at various time points for analysis by 15% Tris-
tricine SDS-PAGE. Protein bands were quantified by using an
Odyssey infrared imaging system (LiCor Biosciences, Lincoln
NE).
Phylogenetic amino acid sequence analysis
Sequences and their annotations were obtained from the Swiss-
Prot Protein knowledgebase. The Clustal W algorithm [71] was
used for sequence alignments and Mega 3 software version 3.1
[72] for phylogenetic analyses. Neighbor joining methods [73]
were used to build phylogenetic trees. Percentage support values
Figure 7. lon-2, but not lon-1, complements an E. coli lon mutant. (A) b-galactosidase activity of wild-type HDB97 (cpsB::lacZ), lon mutant
HDB98 (HDB97lon
510), and HDB98 transformed with empty pBAD24 vector (HDB98pBAD24) or vector containing B. burgdorferi lon-1 (HDB98pBADlon-
1)o rlon-2 (HDB98pBADlon-2). Figure represents the combined data from two independent experiments. HDB97 and HDB98 were cultured in LB
medium and HDB98pBAD24, HDB98pBADlon-1, and HDBpBADlon-2 were cultured in LB medium supplemented with 0.1% arabinose. ***,
significantly different from HDB98, HDB98pBAD24, and HDB98pBADlon-1 (P,0.001, Tukey-Kramer Multiple Comparisons Test). Error bars represent
standard deviations. (B) b-galactosidase activity of E. coli grown with (black bars) and without (white bars) 0.1% arabinose. Figure is representative of
two independent experiments that produced similar results. Error bars in panels A and B represent the standard deviations of triplicate samples. (C, D)
Western blot analysis of culture whole cell lysates from experiment depicted in panel A showing Lon-1 and Lon-2 expression. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a loading control. (E) Solubility of Lon-1 and Lon-2 protein produced by HDB98pBADlon-1 and
HBD98pBADlon-2, respectively. WCL, whole-cell lysate; S, soluble fraction (supernatant) after centrifugation for 10 minutes at 16,0006g. For each E.
coli strain, western blots are shown on the left. Corresponding Coomassie Blue-stained protein is shown on the right to verify that equivalent
amounts of protein were loaded.
doi:10.1371/journal.ppat.1000676.g007
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carried out using nucleotide sequences.
Complementation of E. coli lon mutant HDB98
Wild-type E. coli HDB97 and lon mutant HDB98 (lon510) were
the gift of Dr. Harris D. Bernstein, Genetics and Biochemistry
Branch, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health. B. burgdorferi lon-1 was
amplified from B. burgdorferi strain B31A3 [74] by PCR using
primers P50F and P51R and cloned into the NcoI restriction site
of plasmid pBAD24 [75] which confers ampicillin resistance
(American Type Culture Collection, Manassas, VA). The insert
was placed eight nucleotides downstream from the optimized
ribosomal binding site to form plasmid pBADlon-1. Lon-2 was
amplified by PCR using primers P52R F and P53R and cloned
into a region between the NheI and KpnI restriction sites of
pBAD24, also leaving eight nucleotides between the pBAD24
ribosomal binding site and the lon-2 ATG start site to yield plasmid
pBADlon-2. HDB98 was subsequently transformed with pBADlon-
1 and pBADlon-2 to form strains HDB98pBADlon-1 and
HDB98pBADlon-2. Both constructs were confirmed by nucleotide
sequencing.
b-galactosidase assay
Measurement of b-galactosidase activity of E. coli strains was
done as previously described [76,77]. HDB97 and HDB98, which
contain a cpsB::lacZ reporter fusion, were cultured in LB medium.
HDB98pBAD24 (containing empty pBAD24 vector),
HDB98pBADlon-1 and HDBpBADlon-2 were cultured in LB
medium with ampicillin and 0.1% L-arabinose to induce
expression of B. burgdorferi Lons. Activity units were calculated as
follows:
Units~1000x
Abs600
OD600xVxRT
,
where OD600C represents the optical densityof the culture, V,t h e
culture volume analyzed (ml), RT, the reaction time (min), and
Abs420, the absorbance reading after color development. Each
strain was analyzed in triplicate and the experiment was
repeated a total of five times. Data was tested for statistical
relevance using InStat 3.0 Software (GraphPad Software, Inc.,
San Diego, CA).
Figure 8. lon-2, but not lon-1, complements the filamentous phenotype of an E. coli lon mutant. (A) Brightfield microscopy of E.coli
cultures grown at 37uC for 3.5 hours with or without 0.2% arabinose. Cells were applied to microslides, heat fixed, and visualized by Gram stain. (B)
Western blot showing arabinose-induced Lon-1 and Lon-2 expression after culture at 37uC for 3.5 hours.
doi:10.1371/journal.ppat.1000676.g008
Lon-1 and Lon-2 in Borrelia
PLoS Pathogens | www.plospathogens.org 11 November 2009 | Volume 5 | Issue 11 | e1000676Assays of enzymatic activity
Hydrolysis of casein by B. burgdorferi rLon-1 was used as a
measure of proteolytic activity and was based on the method of
Twining et al. [78]. Preparations of rLon-1 and rLon-1
S714A
contained 20 mM Tris-HCl, 0.5M NaCl, 0.5M imidazole, 0.02%
NP40, and 10% glycerol. To assay for proteolytic activity, 5 mgo f
enzyme was incubated in 1.5 ml microcentrifuge tubes for 3 hours
at 37uC with 100 mg of FITC-labeled casein, type I (Sigma). Final
reaction conditions after addition of Lon proteins were: 50 mM
Tris-HCl, pH 8, 10 mM MgCl2, 4 mM ATP, 25 mM NaCl,
25 mM imidazole, 0.001% NP40, and 0.5% glycerol in a total
volume of 100 ml. In assays designed to test for the influence of
Mg
2+ on rLon-1 proteolytic activity, 10 mM MgCl2 was omitted
from the reaction buffer. Proteolysis was terminated by the
addition of 10 ml of bovine serum albumin (10 mg/ml stock
solution) immediately followed by 100 ml of 10% trichloroacetic
acid (TCA), and 10 minutes of incubation on ice. The reaction
contents were then centrifuged at 16,0006 g to separate TCA
insoluble material. For each sample replicate, 125 ml of the TCA
soluble supernatant fraction was transferred to the well of a 96-well
plate (Falcon - Becton Dickenson) and neutralized by the addition
of 125 ml of 0.5 M CHES-Na, pH 12. Fluorescence was measured
in a SpectraMax M2 microplate reader (Molecular Devices,
Sunnyvale, CA) at wavelengths of 490 nm (excitation) and 525 nm
(emission). The assay for measurement of optimum pH for casein
degradation was carried out at 26uC for 16 hours and the
following buffers were used to achieve the desired assay pH:
50 mM MES (pH 6.0, 6.5, 7.0), 50 mM Tris-HCl (pH 7.5, 8.0,
8.5), 50 mM 2-aminomethanepropanediol-HCl (AMPD) (pH 9.0,
9.5, 10.0), 50 mM CAPS (pH 10.5) [52].
The ATPase activity of rLon-1 and rLon-1
S714A was measured
colorimetrically by use of a kit-based assay which utilized the dye
malachite green to detect the liberation of inorganic phosphate
resulting from enzymatic ATP hydrolysis (Innova Biosciences,
Cambridge, UK). The manufacturer’s protocol was followed for
all assays and utilized 5 mg of enzyme per assay reaction.
Components of the enzyme purification buffer resulted in final
concentrations of 12.5 mM NaCl, 12.5 mM imidazole, 0.0005%
NP40, and 0.25% glycerol in the reaction. Absorbances were
measured in a SpectraMax M2 microplate reader at a wavelength
of 635 nm.
Assay of chaperone-like activity
Reduction of its disulfide bonds induces the separation of insulin
A and B chains with the attendant aggregation of the B chain [63].
The assay for chaperone-like activity is based upon the protection
of reduced B-chain from aggregation by an added chaperone-like
molecule. The degree of protection conferred is monitored by the
measurement of resultant light scattering. In our assay, a
modification of Farahbakhsh et al [79], 15 mg of bovine insulin
was added to 25 mg of wild-type rLon-1 or mutant rLon-1
S714A
protein in the presence of 10 mM sodium phosphate, pH 7.2,
20 mM dithiothreitol, 500 mM NaCl, 50 mM imidazole, 1%
glycerol, 20 mM MgCl2, and either 4 mM or 10 mM ATP (total
volume of 500 ml) in a 1-cm plastic cuvette. Light scattering was
measured over time at 20uC in an Ultrospec 4000 UV/Vis
spectrophotometer (Pharmacia Biotech, Piscataway, NJ) at a
wavelength of 360 nm. A water-jacketed cell changer in
conjunction with a heater/circulator (Neslab Instruments, New-
ington, NH) was used to ensure that the temperature was
maintained. The data were collected and analyzed by SWIFT
software in the kinetics mode (Pharmacia Biotech). Wild-type
rLon-1 and mutant rLon-1
S714A were also analyzed for their
ability to degrade reduced insulin under chaperone assay
conditions. These digestions were carried out in 1.5 ml micro-
centrifuge tubes under the conditions described for the chaperone
assay, with the exceptions that 150 mg of insulin was used.
Incubation was done for 2 hours at 37uC.
SDS-PAGE and western blotting
Tris-glycine SDS-PAGE of recombinant B. burgdorferi Lon
proteins (1 mg) was conducted as described previously [80] in gels
of 12.5% polyacrylamide. For E. coli used in complementation
experiments, 1 ml of culture was centrifuged and resuspended in
100 ml1 6SDS-PAGE sample buffer, and boiled. Samples (10 ml)
were electrophoresed by 12.5% Tris-glycine SDS-PAGE. In all
cases, electrophoretic transfer of protein was carried out over a
period of 16 hours in 0.01M CAPS buffer, pH 11. For analysis of
Lon-1 insulin degradation in the chaperone assay, 100 mlo f
reaction mixture was added to 50 mlo f3 6 SDS-PAGE sample
buffer and boiled. For each condition, 10 ml was electrophoresed
by Tris-tricine SDS-PAGE using a 16.5% separating gel, a 10%
spacer gel, and a 4% stacking gel. Equivalent volumes of degraded
tagged reporter protein (2.2 mg) and insulin (4.5 mg) from SsrA
experiments were analyzed using a 15% Tris-tricine separating gel
alone. For direct staining, the gels were fixed in 50% methanol-
12% acetic acid then stained with 0.1% Coomassie blue R-250 in
50% methanol-12% acetic acid. For western blotting, Lon-1 and
Lon-2 in lysates were detected using rabbit and mouse polyclonal
antiserum, respectively. Infrared-conjugated secondary antibodies
were goat anti-rabbit IgG (H+L) and goat anti-mouse IgG (H+L)
(Rockland, Gilbertsville, PA). Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was detected using goat polyclonal antibody
(GenScript Corp., Piscataway, NJ) and donkey anti-goat IgG
(H+L) secondary antibody. Bands were visualized by use of an
infrared scanner (Odyssey Infrafred Imaging System, LiCor
Biosciences).
Accession/ID numbers for proteins sequences mentioned
in the text
Swiss-Prot Protein knowledgebase: Borrelia burgdorferi Lon-1
(Q59185), Borrelia burgdorferi Lon-2 (O51558), Borrelia recurrentis
Lon-1 (B5RR69), Borrelia recurrentis Lon-2 (B5RPV9), Borrelia duttoni
Lon-1 (B5RL78), Borrelia duttoni Lon-2 (B5RMG3), Borrelia hermsii
Lon-1 (B2RZW3), Borrelia hermsii Lon-2 (B2S0W0), Borrelia garinii
Lon-1 (Q662B2), Borrelia garinii Lon-2 (Q660R0), Borrelia afzelii
Lon-1 (Q0SNQ8), Borrelia afzelii Lon-2 (Q0SMP4), Treponema
pallidum Lon (O83536), Treponema denticola Lon (Q73PX5),
Leptospira biflexa (B0SLS1), Leptospira borgpetersenii (Q04VA7),
Leptospira interrogans (Q72UP9), Escherichia coli Lon (P0A9M0),
Bacillus subtilis Lon (P37945).
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